CONMED PE Ratio 2010-2025 | CNMD

Current and historical p/e ratio for CONMED (CNMD) from 2010 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. CONMED PE ratio as of June 13, 2025 is 12.40.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

CONMED PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-06-13 53.55 14.09
2025-03-31 60.17 $3.80 15.83
2024-12-31 67.96 $4.24 16.03
2024-09-30 71.21 $4.21 16.91
2024-06-30 68.45 $3.14 21.80
2024-03-31 78.86 $2.61 30.22
2023-12-31 107.59 $2.04 52.74
2023-09-30 98.91 $1.85 53.47
2023-06-30 133.03 $2.83 47.01
2023-03-31 101.52 $-3.25 0.00
2022-12-31 86.45 $-2.84 0.00
2022-09-30 78.02 $-2.95 0.00
2022-06-30 93.00 $-3.96 0.00
2022-03-31 143.97 $2.10 68.56
2021-12-31 137.19 $1.94 70.71
2021-09-30 126.42 $2.00 63.21
2021-06-30 132.59 $1.76 75.33
2021-03-31 125.80 $0.39 322.57
2020-12-31 107.72 $0.28 384.72
2020-09-30 75.52 $-0.04 0.00
2020-06-30 68.95 $-0.04 0.00
2020-03-31 54.69 $1.11 49.27
2019-12-31 106.48 $0.95 112.09
2019-09-30 91.39 $1.00 91.39
2019-06-30 81.17 $0.97 83.68
2019-03-31 78.71 $1.08 72.88
2018-12-31 60.60 $1.41 42.98
2018-09-30 74.56 $2.52 29.59
2018-06-30 68.72 $2.58 26.63
2018-03-31 59.29 $2.50 23.72
2017-12-31 47.57 $1.97 24.15
2017-09-30 48.78 $0.56 87.10
2017-06-30 47.17 $0.56 84.23
2017-03-31 40.97 $0.44 93.10
2016-12-31 40.54 $0.52 77.97
2016-09-30 36.61 $0.56 65.37
2016-06-30 43.40 $0.62 70.01
2016-03-31 37.96 $0.79 48.05
2015-12-31 39.67 $1.10 36.07
2015-09-30 42.79 $1.23 34.79
2015-06-30 52.03 $0.98 53.09
2015-03-31 44.92 $1.08 41.59
2014-12-31 39.84 $1.16 34.35
2014-09-30 32.50 $1.11 29.28
2014-06-30 38.75 $1.24 31.25
2014-03-31 37.96 $1.21 31.37
2013-12-31 36.97 $1.27 29.11
2013-09-30 29.39 $1.29 22.78
2013-06-30 26.92 $1.41 19.09
2013-03-31 29.21 $1.43 20.42
2012-12-31 23.86 $1.41 16.92
2012-09-30 24.19 $0.13 186.10
2012-06-30 23.36 $0.10 233.61
2012-03-31 25.08 $0.04 626.92
2011-12-31 21.44 $0.00 0.00
2011-09-30 19.22 $1.14 16.86
2011-06-30 23.79 $1.16 20.51
2011-03-31 21.95 $1.11 19.77
2010-12-31 22.08 $1.05 21.02
2010-09-30 18.72 $0.98 19.10
2010-06-30 15.56 $0.71 21.92
2010-03-31 19.89 $0.51 38.99
2009-12-31 19.04 $0.41 46.45
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $1.657B $1.307B
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $91.107B 22.00
Becton Dickinson (BDX) United States $49.357B 12.22
Cardinal Health (CAH) United States $38.525B 20.18
Labcorp Holdings (LH) United States $21.856B 17.73
Straumann Holding AG (SAUHY) Switzerland $20.436B 0.00
West Pharmaceutical Services (WST) United States $15.943B 33.42
Cooper (COO) United States $13.939B 17.96
Align Technology (ALGN) United States $12.891B 25.59
Henry Schein (HSIC) United States $8.544B 14.65
Merit Medical Systems (MMSI) United States $5.495B 26.56
DENTSPLY SIRONA (XRAY) United States $3.115B 9.30
STAAR Surgical (STAA) United States $0.846B 0.00
Lifevantage (LFVN) United States $0.156B 16.14
Pro-Dex (PDEX) United States $0.129B 14.13